Emergent BioSolutions to Release Second Quarter 2020 Financial Results and Conduct Conference Call on July 30, 2020
July 16, 2020 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., July 16, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 30, 2020 at 5:00 pm (Eastern Time) to discuss the financial...
Emergent BioSolutions Reports Financial Results for First Quarter 2020
April 30, 2020 16:08 ET
|
Emergent BioSolutions
Reaffirms full year 2020 financial forecastExecutes multi-faceted response to COVID-19 drawing upon longstanding investments in capabilities to address public health threats, as well as expertise in...
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2019
February 20, 2020 16:31 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2019. FINANCIAL HIGHLIGHTS (in...
Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2019
November 06, 2019 16:05 ET
|
Emergent BioSolutions
Q3 2019 performance above guidance Full year 2019 financial forecast reaffirmed GAITHERSBURG, Md., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial...
Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2019
August 01, 2019 16:05 ET
|
Emergent BioSolutions
Reaffirms full year 2019 financial forecast and operational goalsProvides Q3 2019 revenue forecast of $245M-$275M GAITHERSBURG, Md., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc....
Emergent BioSolutions to Release Second Quarter 2019 Financial Results and Conduct a Conference Call on August 1, 2019
July 18, 2019 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., July 18, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, August 1, 2019 at 5:00 pm (Eastern Time) to discuss the financial...
Emergent BioSolutions Reports First Quarter 2019 Financial Results
May 02, 2019 16:05 ET
|
Emergent BioSolutions
Reaffirms full year 2019 financial forecast and operational goalsProvides Q2 2019 revenue forecast of $200M-$220M GAITHERSBURG, Md., May 02, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc....
Emergent BioSolutions to Release First Quarter 2019 Financial Results and Conduct a Conference Call on May 2, 2019
April 18, 2019 07:22 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., April 18, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, May 2, 2019 at 5:00 pm (Eastern Time) to discuss the financial...
Emergent BioSolutions Reports Fourth Quarter and Full Year 2018 Financial Results
February 21, 2019 16:05 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2018. FINANCIAL HIGHLIGHTS (in...
Emergent BioSolutions to Release Third Quarter 2018 Financial Results and Conduct a Conference Call on November 1, 2018
October 11, 2018 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 1, 2018 at 5:00 pm (Eastern Time) to discuss the...